Sepracor Expands Within Marlborough, Mass., Office-Lab Building
Sepracor has signed a lease for 32,477 square feet of additional space at 33 Locke Drive in Marlborough, Mass. The lease expands Sepracor’s presence in the building to 57,477 square feet on two floors.
The pharmaceutical company has both office and chemistry lab space in the 60,477-square-foot building, situated along Interstate 495 and owned by Northland Investment Corporation. Northland was represented by Paul Leone, John Lashar, and Michael Frisoli, all of Richards Barry Joyce & Partners, the Boston commercial real estate brokerage that announced the lease deal July 23.
Sepracor is headquartered nearby within Marlborough, at 84 Waterford Drive.
Aradigm Enters Sublease Agreement with Mendel Biotechnology
Aradigm, a specialty pharmaceutical company, has subleased approximately 54,000 square feet in its headquarters facility, 3929 Point Eden Way in Hayward, Calif., to Mendel Biotechnology, under an agreement that took effect July 18 and was announced five days later.
Scott Stone and Garrett Krueger of Aegis Realty Partners — the Oakland brokerage that announced the deal July 23 — represented Aradigm in the sublease deal, which followed a recent corporate restructuring. Aradigm will continue to occupy part of the facility and sustain all operations. Mendel Biotechnology is a plant biotechnology company that required more space for an expansion that followed what the company called “a recent funding event.” Representing Mendel were Bob Ferraro and Mark Kol, both from the Oakland office of CB Richard Ellis.